CA2815109C - Cysteine and food intake - Google Patents

Cysteine and food intake Download PDF

Info

Publication number
CA2815109C
CA2815109C CA2815109A CA2815109A CA2815109C CA 2815109 C CA2815109 C CA 2815109C CA 2815109 A CA2815109 A CA 2815109A CA 2815109 A CA2815109 A CA 2815109A CA 2815109 C CA2815109 C CA 2815109C
Authority
CA
Canada
Prior art keywords
cysteine
nutritional composition
malnutrition
composition
food intake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2815109A
Other languages
English (en)
French (fr)
Other versions
CA2815109A1 (en
Inventor
Denis Breuille
Isabelle Papet
Karine Vidal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement
Original Assignee
Societe des Produits Nestle SA
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43304791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2815109(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Institut National de la Recherche Agronomique INRA filed Critical Societe des Produits Nestle SA
Publication of CA2815109A1 publication Critical patent/CA2815109A1/en
Application granted granted Critical
Publication of CA2815109C publication Critical patent/CA2815109C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
CA2815109A 2010-10-21 2011-10-19 Cysteine and food intake Active CA2815109C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10188399.9 2010-10-21
EP10188399A EP2444083A1 (en) 2010-10-21 2010-10-21 Cysteine and food intake
PCT/EP2011/068231 WO2012052463A1 (en) 2010-10-21 2011-10-19 Cysteine and food intake

Publications (2)

Publication Number Publication Date
CA2815109A1 CA2815109A1 (en) 2012-04-26
CA2815109C true CA2815109C (en) 2020-03-24

Family

ID=43304791

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2815109A Active CA2815109C (en) 2010-10-21 2011-10-19 Cysteine and food intake

Country Status (15)

Country Link
US (1) US9233090B2 (https=)
EP (2) EP2444083A1 (https=)
JP (1) JP6160832B2 (https=)
CN (1) CN103269697A (https=)
AU (1) AU2011317627B2 (https=)
BR (1) BR112013009709A2 (https=)
CA (1) CA2815109C (https=)
DK (1) DK2629769T3 (https=)
ES (1) ES2654344T3 (https=)
MX (1) MX2013004371A (https=)
PH (1) PH12013500761A1 (https=)
RU (1) RU2013123062A (https=)
SG (1) SG189935A1 (https=)
WO (1) WO2012052463A1 (https=)
ZA (1) ZA201303656B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
CN111315239A (zh) * 2017-11-21 2020-06-19 雀巢产品有限公司 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
WO2020163188A1 (en) * 2019-02-08 2020-08-13 Imbria Pharmaceuticals, Inc. Compositions containing n-acetylcysteine conjugated to a tca cycle intermediate
JP7655224B2 (ja) * 2019-10-25 2025-04-02 味の素株式会社 筋質向上剤
CN120282718A (zh) 2022-09-30 2025-07-08 赢创运营有限公司 用于治疗营养不良的益生菌组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
JPS62286923A (ja) * 1986-06-04 1987-12-12 Takao Shinoda 貧食作用増強剤
JPH05294833A (ja) * 1991-04-15 1993-11-09 Takeda Chem Ind Ltd ビタミン含有保健剤
WO1993002682A1 (en) 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
DE4229166A1 (de) * 1992-09-01 1994-03-03 Deutsches Krebsforsch Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
US5627152A (en) * 1995-01-18 1997-05-06 Telluride Pharmaceutical Corporation Method for increasing bodyweight
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
RO119122B1 (ro) * 1998-02-02 2004-04-30 Dumitru Dobrescu Medicament geriatric
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
PL363426A1 (en) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20090209647A1 (en) 2005-06-14 2009-08-20 Nestec S.A. Nutritional method
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
JP2009001507A (ja) 2007-06-19 2009-01-08 Ss Pharmaceut Co Ltd 体脂肪減少剤およびその利用
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
TWI515005B (zh) 2008-09-12 2016-01-01 ２４５８７８１加拿大公司 在接受化療或放療的患者中應用富含半胱胺酸之乳清衍生蛋白以增進患者存活時間
CA2740911C (en) 2008-10-17 2014-07-29 Nestec S.A. Whey protein compositions, methods and uses

Also Published As

Publication number Publication date
AU2011317627B2 (en) 2016-06-02
BR112013009709A2 (pt) 2016-07-19
EP2444083A1 (en) 2012-04-25
JP2014504261A (ja) 2014-02-20
EP2629769A1 (en) 2013-08-28
WO2012052463A1 (en) 2012-04-26
JP6160832B2 (ja) 2017-07-12
CA2815109A1 (en) 2012-04-26
MX2013004371A (es) 2013-08-27
CN103269697A (zh) 2013-08-28
DK2629769T3 (en) 2018-01-02
SG189935A1 (en) 2013-06-28
AU2011317627A1 (en) 2013-05-23
PH12013500761A1 (en) 2017-08-23
EP2629769B1 (en) 2017-10-04
RU2013123062A (ru) 2014-11-27
US9233090B2 (en) 2016-01-12
ZA201303656B (en) 2014-11-26
ES2654344T3 (es) 2018-02-13
US20130225486A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
CA2815109C (en) Cysteine and food intake
AU2004222633B2 (en) Compositions comprising fatty acids and amino acids
KR102100091B1 (ko) 영양 조성물
US8840950B2 (en) Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
CN103974631A (zh) 在固定诱导的肌肉萎缩后加速肌肉恢复
JP2024122087A (ja) 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法
BR112015030767B1 (pt) Uso de uma composição
JP2014504261A5 (https=)
AU2010305420B2 (en) GLP-2 for use in intestine and muscle recovery
CN105451732B (zh) 脂质代谢促进剂
CN108697679A (zh) 含氨基酸的组合物
JP2019108364A (ja) 栄養組成物
KR20040077682A (ko) 변형 메티오닌 풍부 식품 및 그의 제조방법
JP2011046647A (ja) ポリ−γ−グルタミン酸を含有するコレステロール抑制剤
JP2019024389A (ja) 筋力向上用アミノ酸組成物
BR112020019737A2 (pt) uso de uma composição
WO2013018706A1 (ja) Ｕｒａｔ１活性を調節するための組成物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160919

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240904

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240904

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240904

R00 Party data change recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R00-R116 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUEST

Effective date: 20240906

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R00-R119 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUEST

Effective date: 20240906

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250403

R17 Change to representative recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R17-R121 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REVOCATION OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250501

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R17-R117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPOINTMENT OF AGENT REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250501

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250501

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250902

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250902